πŸ‡ΊπŸ‡Έ FDA
Patent

US 12343342

Methods for treating soft tissue sarcoma

granted A61KA61K31/197A61K31/34

Quick answer

US patent 12343342 (Methods for treating soft tissue sarcoma) held by Lixte Biotechnology, Inc. expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Lixte Biotechnology, Inc.
Grant date
Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/197, A61K31/34, A61K31/4525, A61K31/496